GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Sale Of Business

Biolife Sciences (Biolife Sciences) Sale Of Business : $0.00 Mil (TTM As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Sale Of Business?

Biolife Sciences's sale of business for the three months ended in May. 2008 was $0.00 Mil. It means Biolife Sciences gained $0.00 Mil from selling business. Biolife Sciences's sale of business for the trailing twelve months (TTM) ended in May. 2008 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Feb. 2008 ), Biolife Sciences gained the same money from selling business in May. 2008 ($0.00 Mil).


Biolife Sciences Sale Of Business Historical Data

The historical data trend for Biolife Sciences's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Sale Of Business Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Sale Of Business
- - - -

Biolife Sciences Quarterly Data
Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biolife Sciences Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in May. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biolife Sciences Sale Of Business Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020